Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC

Naoko Katsurada,1 Motoko Tachihara,1 Yukihisa Hatakeyama,1 Kiyoko Koyama,1 Masako Yumura,1 Tatsunori Kiriu,1 Ryota Dokuni,1 Daisuke Hazama,1 Shuntaro Tokunaga,1 Daisuke Tamura,1 Kyosuke Nakata,1 Masatsugu Yamamoto,1 Hiroshi Kamiryo,1 Kazuyuki Kobayashi,1 Yugo Tanaka,2 Yoshimasa Maniwa,2 Yoshihiro Ni...

Full description

Bibliographic Details
Main Authors: Katsurada N, Tachihara M, Hatakeyama Y, Koyama K, Yumura M, Kiriu T, Dokuni R, Hazama D, Tokunaga S, Tamura D, Nakata K, Yamamoto M, Kamiryo H, Kobayashi K, Tanaka Y, Maniwa Y, Nishimura Y
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Cancer Management and Research
Subjects:
nab-paclitaxel
carboplatin
adjuvant chemotherapy
non-small cell cancer
Online Access:https://www.dovepress.com/feasibility-study-of-adjuvant-chemotherapy-with-carboplatin-and-nab-pa-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/feasibility-study-of-adjuvant-chemotherapy-with-carboplatin-and-nab-pa-peer-reviewed-article-CMAR

Similar Items